The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Drucker, D. J., Buse, J. B., Taylor, K., Kendall, D. M., Trautmann, M., Zhuang, D., & Porter, L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61206-4 · Cited by 1,070
What does it mean to be natively unfolded?
Uversky, V. N. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02649.x · Cited by 982
The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel Therapeutics
Fishburn, C. S. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21278 · Cited by 474
Baggio, L. L., Huang, Q., Brown, T. J., & Drucker, D. J. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2492 · Cited by 386
Advances in PEGylation of important biotech molecules: delivery aspects
Ryan, S. M., Mantovani, G., Wang, X., Haddleton, D. M., & Brayden, D. J. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.4.371 · Cited by 323
Richter, A. W., & Åkerblom, E. (1983) · International Archives of Allergy and Immunology · doi:10.1159/000233309 · Cited by 282
Bendele, A. M., Seely, J., Richey, C., Sennello, G., & Shopp, G. M. (1998) · Toxicological Sciences · doi:10.1006/toxs.1997.2396 · Cited by 279
Site-specific PEGylation of native disulfide bonds in therapeutic proteins
Shaunak, S., Godwin, A., Choi, J.-W., Balan, S., Pedone, E., Vijayarangam, D., Heidelberger, S., Teo, I., Zloh, M., & Brocchini, S. (2006) · Nature Chemical Biology · doi:10.1038/nchembio786 · Cited by 261
Folta‐Stogniew, E. J., & Williams, K. R. (1999) · PubMed · Cited by 177
Site-Specific Attachment of Functionalized Poly(ethylene glycol) to the Amino Terminus of Proteins
Gaertner, H. F., & Offord, R. E. (1996) · Bioconjugate Chemistry · doi:10.1021/bc950074d · Cited by 174
MAHMOOD, I. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.015 · Cited by 170
Repeated injections of PEG-PE liposomes generate anti-PEG antibodies.
Środa-Pomianek, K., Rydlewski, J., Langner, M., Kozubek, A., Grzybek, M., & Sikorski, A. F. (2005) · PubMed · Cited by 116
Dhalluin, C., Ross, A., Leuthold, L. A., Foser, S., Gsell, B., Müller, F., & Senn, H. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049781+ · Cited by 114
Schlapschy, M., Theobald, I., Mack, H. I. D., et al. (2007) · Protein Engineering Design and Selection · doi:10.1093/protein/gzm020 · Cited by 98
He, X., Shaw, P., & Tam, S.-C. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00257-x · Cited by 93
Huang, L., Gough, P. C., & DeFelippis, M. R. (2008) · Analytical Chemistry · doi:10.1021/ac801711u · Cited by 81
Pegylated interferons: What role will they play in the treatment of chronic hepatitis c?
Shiffman, M. L. (2001) · Current Gastroenterology Reports · doi:10.1007/s11894-001-0038-z · Cited by 41
Huang, Y., Chen, Z., Chen, Y., Guo‐Chang, M. A., Shan, J., Liu, W., & Zhou, L. (2007) · Journal of Peptide Science · doi:10.1002/psc.942 · Cited by 41
Structural characterization of PEGylated rHuG-CSF and location of PEG attachment sites
Cindrić, M., Čepo, T., Galić, N., Bukvić-Krajačić, M., Tomczyk, N., Vissers, J. P. C., Bîndilă, L., & Peter‐Katalinić, J. (2007) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2007.02.036 · Cited by 38
Improving Protein Pharmacokinetics by Genetic Fusion to Simple Amino Acid Sequences
Alvarez, P., Buscaglia, C. A., & Campetella, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311356200 · Cited by 33
Glucagon metabolism in nonhuman primate pregnancy
Chez, R. A., Mintz, D. H., Epstein, M. F., Fleischman, A. R., Oakes, G. K., & Hutchinson, D. L. (1974) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(74)90612-7 · Cited by 23
Chemical and biological properties of polymer-modified proteins
Kochendoerfer, G. G. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.8.1253 · Cited by 21
Single- and multiple-dose pharmacokinetics of exendin-4 in rhesus monkeys
AI, G., CHEN, Z., SHAN, C., Che, J., Hou, Y., & Cheng, Y. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.016 · Cited by 18
Pegylated interferons: What role will they play in the treatment of chronic hepatitis C?
Shiffman, M. L. (2003) · Current Hepatology Reports · doi:10.1007/s11901-003-0010-5 · Cited by 10
Cited by
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Fusion protein linkers: Property, design and functionality
Chen, X., Zaro, J. L., & Shen, W.-C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.039 · Cited by 2,056
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Guilinger, J. P., Thompson, D. B., & Liu, D. R. (2014) · Nature Biotechnology · doi:10.1038/nbt.2909 · Cited by 836
Metadata
- Authors
- Schellenberger, V., Wang, C.-W., Geething, N. C., Spink, B. J., Campbell, A., To, W., Scholle, M. D., Yin, Y., Yao, Y., Bogin, O., Cleland, J. L., Silverman, J., & Stemmer, W. P. C.
- Venue
- Nature Biotechnology
- Published
- 2009-11-15
- Volume
- 27
- Issue
- 12
- Pages
- 1186-1190
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2073047768
- Cited by
- 462
- References
- 25
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.